$ALLR Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months
Data presented at the American Association for Cancer Research (AACR)
$AEM (Agnico Eagle)’s uptrend paused at $55. RSI is 60, no gold mining news. Even precious metal stocks need a breather. If it can’t break $57, a pullback to $53 (key support) is possible.